In effect, Trump is running against Congress, and now he wants the GOP members of the House and Senate to join his campaign. Read more
A group of U.S. Senators has urged President Barack Obama to call for legislation banning so-called pay-for-delay deals among drugmakers that drive up prescription drug prices. Read more
The new FDA commissioner, Dr. Robert M. Califf, says he supports a new surveillance program for medical devices that relies on data. Read more
The FDA also requested $75 million to pay for a virtual cancer research center for the development new diagnostic tests and treatments. Read more
Faced with record numbers of automotive recalls and harsh criticism for failing to adequately police the auto industry, The National Highway Traffic Safety Administration is asking Congress... Read more
The transportation bill approved last month by the U.S. House of Representatives would put a new emphasis on freight corridors when designating highway funds. It also includes provisions sou... Read more
The U.S. Senate passed a bill that will triple the maximum fines automakers pay for violations of motor-vehicle safety laws. The new $105 million cap was part of a six-year surface transport... Read more
Every time I start to believe that members of Congress actually understand the basic principle that safety on our highways is a good thing, something happens in Washington to bring me back d... Read more
Within the past few years, the cost for generic prescription drugs has skyrocketed with prices increasing more than 1,000 percent in some cases. Nearly 10 percent of generic drugs more than... Read more
Fen Phen, Lotronex, Propulsid, Rezulin, Baycol, Vioxx, Bextra, Avandia, and Meridia – what do these pharmaceutical drugs have in common? Each was rushed to the market without adequate safety... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.